Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. News
  7. Summary
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Everest Medicines : Nomura Starts Everest Medicines at Buy With HK$110 Price Target

03/19/2021 | 04:46am EDT


ę MT Newswires 2021
All news about EVEREST MEDICINES LIMITED
10/09Certain Shares of Everest Medicines Limited are subject to a Lock-Up Agreement Ending o..
CI
10/04Everest Medicines Limited commences an Equity Buyback Plan for 29,684,786 shares, repre..
CI
09/30EVEREST MEDICINES' : New Drug Application for Complicated Intra-Abdominal Infections Treat..
MT
09/29Everest Medicines Initiates Submission of New Drug Application in Hong Kong for XeravaT..
CI
09/29EVEREST MEDICINES : Initiates Submission of New Drug Application in Hong Kong for XeravaTM..
PR
09/29Everest Medicines Limited Business Update on the Submission of New Drug Application in ..
CI
09/24EVEREST MEDICINES : Wins Nod to Begin Clinical Trial of Novel Bacterial Infections Treatme..
MT
09/24EVEREST MEDICINES : Announces Approval of Investigational New Drug Application by China NM..
PR
09/24Everest Medicines Limited Receives Approval for Investigational New Drug Application fo..
CI
09/23Health Care Stocks Slightly Higher in Premarket Thursday
MT
More news
Analyst Recommendations on EVEREST MEDICINES LIMITED
More recommendations
Financials
Sales 2021 1,92 M 0,30 M 0,30 M
Net income 2021 -1 046 M -163 M -163 M
Net cash 2021 3 029 M 473 M 473 M
P/E ratio 2021 -10,8x
Yield 2021 -
Capitalization 11 523 M 1 803 M 1 801 M
EV / Sales 2021 4 432x
EV / Sales 2022 12,4x
Nbr of Employees 227
Free-Float 98,1%
Chart EVEREST MEDICINES LIMITED
Duration : Period :
Everest Medicines Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVEREST MEDICINES LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 38,74 CNY
Average target price 85,27 CNY
Spread / Average Target 120%
EPS Revisions
Managers and Directors
Kerry Levan Blanchard Chief Executive Officer & Executive Director
Ian Ying Woo President, CFO & Executive Director
Wei Fu Chairman
Jennifer Yang Chief Scientific Officer
Xiaofan Zhang Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EVEREST MEDICINES LIMITED-30.35%1 803
CSL LIMITED5.58%102 349
WUXI BIOLOGICS (CAYMAN) INC.14.30%64 102
SAMSUNG BIOLOGICS CO.,LTD.8.72%50 698
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.72%38 185